Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas

British Journal of Cancer

Volumn 90, Issue 3, 2004, Pages 728-735

  Chou, S C ^a   Azuma, Y ^a   Varia, M A ^a   Raleigh, J A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Hypoxia; Involucrin; Oxygen regulation; Pimonidazole

Indexed keywords

BIOCHEMICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1; INVOLUCRIN; OXYGEN; PIMONIDAZOLE; PROTEIN PRECURSOR; TUMOR MARKER; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; OXYGEN; PROTEIN PRECURSORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 1542269248     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601585     Document Type: Article

References (69)

1. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ (2003) GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104: 85-91
2. Arteel G, Thurman R, Raleigh J (1998) Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 253: 743-750
3. Arteel GE, Thurman RG, Yates JM, Raleigh JA (1995) Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889-895
4. Auersperg N, Kruk PA, MacLaren IA, Watt FM, Mydral SE (1989) Heterogeneous expression of keratin, involucrin, and extracellular matrix among subpopulations of a poorly differentiated human cervical carcinoma: possible relationships to patterns of invasion. Cancer Res 49: 3007-3014
5. Azuma Y, Chou S-C, Lininger RA, Murphy BJ, Varia MA, Raleigh JA (2003) Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin. Cl Cancer Res 9: 4944-4952
6. Bandyopadhyay RS, Phelan M, Faller DV (1995) Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim Biophys Acta 1264: 72-78
7. Boag J (1969) Oxygen diffusion and oxygen depletion problems in radiobiology. Curr Top Radiat Res 5: 141-195
8. Chiarotto JA, Hill RP (1999) A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines. Br J Cancer 80: 1518-1524
9. Claffey KP, Wilkison WO, Spiegelman BM (1992) Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267: 16317-16322
10. Crish JF, Bone F, Banks EB, Eckert RL (2002) The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation. Oncogene 21: 738-747
11. Denda M, Hosoi J, Asida Y (2000) Visual imaging of ion distribution in human epidermis. Biochem Biophys Res Commun 272: 134-137
12. Eckert RL, Welter JF (1996) Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Rep 23: 59-70
13. Efimova T, LaCelle P, Welter JF, Eckert RL (1998) Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway. Biol Chem 273: 24387-24395
14. Franko AJ, Koch CJ, Garrecht BM, Sharplin J, Hughes D (1987) Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res 47: 5367-5376
15. Franko AJ, Parliament MB, Allalunis-Turner MJ, Wolokoff BG (1998) Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines. Br J Cancer 78: 1261-1268
16. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687
17. Gaido KW, Maness SC (1994) Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8- tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 127: 199-208
18. Gibson DF, Ratnam AV, Bikle DD (1996) Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J Invest Dermatol 106: 154-161
19. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W (1995) Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 61: 567-573
20. Hallows KR, Bliven SF, Leith JT (1988) Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells. Radiat Res 113: 191-198
21. Haugland HK, Vukovic V, Pintilie M, Fyles AW, Milosevic M, Hill RP, Hedley DW (2002) Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 53: 854-861
22. Helczynska K, Kronblad A, Jogi A, Nilsson E, Beckman S, Landberg G, Pahlman S (2003) Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 63: 1441-1444
23. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P (1996a) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515
24. Hockel M, Schlenger K, Hockel S, Vaupel P (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59: 4525-4528
25. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P (1996b) Hypoxia and radiation response in human tumors. Sem Rad Oncol 6: 3-9
26. Hoffmann W, Blase MA, Santo-Hoeltje L, Herskind C, Bamberg M, Rodemann HP (1999) Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha. Int J Radiat Oncol Biol Phys 45: 991-998
27. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC (2002) HIF-1alpha, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 54: 1537-1549
28. 2 tension. Am J Physiol 271: C1172-1180
29. Jones DP (1985) The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In: Oxidative Stress, Sies H (ed) pp 151-195. New York: Academic Press
30. Kaanders HAM, Wijffels KIEM, Marres HAM, Ljungkvist ASE, Pop LAM, van den Hoogen FJA, de Wilde PCM, Bussink J, Raleigh JA, van der Kogel AJ (2002) Patient selection for hypoxia-modifying treatments based on pimonidazole binding and tumor vascularity. Cancer Res 62: 7066-7074
31. Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ (2002) Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1alpha stabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res 62: 4469-4477
32. Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA (1997) Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys 37: 897-905
33. Koch CJ, Evans SM, Lord EM (1995) Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer 72: 869-874
34. Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li GC, Mendonca HL, Ryan HE, Wang Z, Johnson RS (2002) The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol 22: 2515-2523
35. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW (2001) Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 220: 175-186
36. Leith JT, Michelson S (1995) Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif 28: 415-430
37. Levy FH, Kelly DP (1997) Regulation of ATP synthase subunit e gene expression by hypoxia: cell differentiation stage-specific control. Am J Physiol 272: C457-C465
38. Murphy BJ, Andrews GK, Bittel D, Discher DJ, McCue J, Green CJ, Yanovsky M, Giaccia A, Sutherland RM, Laderoute KR, Webster KA (1999) Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res 59: 1315-1322
39. Nordsmark M, Overgaard M, Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39
40. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61: 8924-8929
41. Parliament MB, Franko AJ, Allalunis-Turner MJ, Mielke BW, Santos CL, Wolokoff BG, Mercer JR (1997) Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption. Br J Cancer 75: 311-318
42. Pigott KH, Hill SA, Chaplin DJ, Saunders MI (1996) Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol 40: 45-50
43. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD (1994) Induction of a new metallothionein (MT-IV) during differentiation of stratified squamous epithelia. Biochemistry 33: 7250-7259
44. Raleigh J, Chou S-C, Calkins-Adams D, Ballenger C, Novotny D, Varia M (2000) A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas. Clin Cancer Res 6: 855-862
45. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC, Novotny DB, Varia MA (1998a) Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58: 3765-3768
46. Raleigh JA, Chou S-C, Arteel GE, Horsman MR (1999) Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors. Radiat Res 151: 580-589
47. Raleigh JA, Chou S-C, Tables LL, Suchindran S, Varia MA, Horsman MR (1998b) Relationship of hypoxia to metallothionein expression in murine tumors. Int J Radiat Oncol Biol Phys 42: 727-730
48. Raleigh JA, La Dine JK, Cline JM, Thrall DE (1994) An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Br J Cancer 69: 66-71
49. Rheinwald JG, Beckett MA (1980) Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22: 629-632
50. Rheinwald JG, Beckett MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41: 1657-1663
51. Rice RH, Rong XH, Chakravarty R (1988) Suppression of keratinocyte differentiation in SSC-9 human squamous carcinoma cells by benzo[a]pyrene, 12-O-tetradecanoylphorbol-13-acetate and hydroxyurea. Carcinogenesis 9: 1885-1890
52. Roland NJ, Rowley H, Scraggs M, Johnson P, Jones AS (1996) MIB-1 and involucrin expression in laryngeal squamous carcinoma: the relationship to host and tumour factors and survival. Clin Otolaryngol 21: 429-438
53. Sahai A, Mei C, Zavosh A, Tannen RL (1997) Chronic hypoxia induces LLC-PK1 cell proliferation and dedifferentiation by the activation of protein kinase C. Am J Physiol 272: F809-F815
54. Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K, Blagosklonny MV (2002) The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 22: 1734-1741
55. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845
56. Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB (1997) Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 33: 1860-1864
57. Takahashi H, lizuka H (1993) Analysis of the 5′-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13- acetate. J Invest Dermatol 100: 10-15
58. Thrall DE, McEntee MC, Cline JM, Raleigh JA (1994) ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation. Int J Radiat Oncol Biol Phys 28: 649-659
59. Turcotte ML, Parliament M, Franko A, Allalunis-Turner J (2002) Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells. Br J Cancer 86: 619-624
60. Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D, Harris AL (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62: 2957-2961
61. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC, Raleigh JA (1998) Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71: 270-277
62. Viac J, Palacio S, Schmitt D, Claudy A (1997) Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 289: 158-163
63. Watt FM (1983) Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81: 100s-103s
64. Webster KA, Gunning P, Hardeman E, Wallace DC, Kedes L (1990) Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts. J Cell Physiol 142: 566-573
65. Wheeler KT, Wierowski JV (1983) DNA accessibility: a determinant of mammalian cell differentiation? Radiat Res 93: 312-318
66. Whillans DW, Rauth AM (1980) An analysis of changes in oxygen tension in stirred cellular suspensions under conditions of radiolytic and cellular consumption. Cancer Clin Trials 3: 63-67
67. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jurgensen JS, Gruber G, Maxwell PH, Loning SA, Frei U, Maher ER, Grone HJ, Eckardt KU (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 61: 5215-5222
68. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083
69. Zhong Z, Arteel GE, Connor HD, Yin M, vonFrankenberg M, Stachlewitz RF, Raleigh JA, Mason RP, Thurman RG (1998) Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 275 (Renal Physiol): F595-F604